You are here » Home » Companies » Company Overview » Fermenta Biotech Ltd

Fermenta Biotech Ltd.

BSE: 506414 Sector: Health care
NSE: N.A. ISIN Code: INE225B01021
BSE 00:00 | 21 Jan 296.10 6.20
(2.14%)
OPEN

293.00

HIGH

314.85

LOW

293.00

NSE 05:30 | 01 Jan Fermenta Biotech Ltd
OPEN 293.00
PREVIOUS CLOSE 289.90
VOLUME 53749
52-Week high 370.00
52-Week low 249.00
P/E 21.76
Mkt Cap.(Rs cr) 872
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 293.00
CLOSE 289.90
VOLUME 53749
52-Week high 370.00
52-Week low 249.00
P/E 21.76
Mkt Cap.(Rs cr) 872
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Fermenta Biotech Ltd. (FERMENTABIOTEC) - Company History

Promoted by a technocrat D V K Raju Duphar-Interfran (DIL) was incorporated in May '51 as International Franchises Pvt Ltd. In the initial years the company manufactured and sold toothpaste anti-septic lotion and pharmaceutical specialities on a loan-licence basis. It entered into collaborations with Philips-Duphar Amsterdam (Solvay Duphar) and the Crookes Laboratories London. These collaborators participated in the equity capital of the company to the extent of 25% each.The company changed its name to Crookes Interfran on 19 Apr.'63. In 1964 it entered into a collaboration with Solvay Duphar to manufacture vitamin D3. To associate fully with its research-oriented collaborators in May '71 it changed its name to Duphar-Interfran. In 1976 it entered into another collaboration with Solvay Duphar to manufacture isoxypurine hydrochloride -- a vasodilator. In 1976 in compliance with the FERA the foreign collaborators reduced thier stake to 38.86%.DIL came out with a rights issue in May '95 to augment long-term resources and working capital requirements. The company also sold its popular analgesic brand Crocin to Smithkline Beecham Pharmaceuticals. It also sold another OTC brand Lacto-Calamine lotion to Nicholas Piramal to concentrate on the core business of ethical drugs.As per the Scheme of Arrangement the pharma business of the company has been transferred to a new company called Duphar Pharma India. The Company has made investments in unutilised premises at Thane to create a commercial complex with modern facilities so that substantial portion of it can be let out to earn income. The successful entry of Annual Contract with Solvay Pharmaceuticals B V of Netherlands will definitely establish as a reliable contract research organization for Duphar Interfran Ltd. As mutual consent with Solvay PharmaceuticalsNetherlandsthe company has been permitted to continue with the name DUPHAR for a limited time. It has also been decided to change the name to DIL Limited from Duphar-Interfran Ltd.With the prior approval from Board the company has acquired 990000 equity shares of Rs.10 each in Fermenta Biotech Ltd there by increase its holding to 83.71% comprising 1657500 equity shares. Subsequent to this FBL will henceforth be a subsidiary of Duphar Interfran Ltd.

.